University of Texas Arlington: Future of Immunotherapy Could Be 'Off-the-Shelf' Treatments
March 02, 2021
March 02, 2021
ARLINGTON, Texas, March 2 (TNSJou) -- The University of Texas Arlington campus issued the following news release:
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
Jon Weidanz, who also is a professor in the College of Nursing and Health Innovation at U . . .
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
Jon Weidanz, who also is a professor in the College of Nursing and Health Innovation at U . . .